About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Dr. Robert L Horvath MBBS (USyd) FRACP FRCPA
Robert Horvath is an Australian based infectious diseases physician at The Prince Charles Hospital (TPCH) in Brisbane, and a Microbiologist at Pathology Queensland.His career spanned Eastern Australia, including periods in rural or remote regions.In 2015 He co-founded with John Sedgwick the Infective Endocarditis Working Group (IEWG) which evolved into ieQ (infective endocarditis Queensland) in 2018 which amongst other functions, provides a weekly statewide endocarditis MDT service for complex cases (most extensive endocarditis MDT service in Australia). He co-founded ACE (Australasian Collaboration in Endocarditis) during 2022 and is currently the chair. He also is a co-founder of QFIG (Q fever Interest Group), established 2021 and was elected chair during 2026. He was a convenor of the 2019 ieQ national Endocarditis Symposium, and 2024 ACE international Endocarditis Symposium both held at TPCH, and the QFIG Q fever international hybrid weekend symposium held at Byron Bay NSW during June 2025. QFIG also offers MDT advice for complex Q fever cases. During 2025, both ACE and QFIG have expanded internationally, including offering MDT advice for complex patients. Both ACE and QFIG are in the process of developing international registries as well as networking for research into these conditions. Robert is also developing dedicated international websites for both ACE and QFIG to increase international collaborations.
Host: Dr. Israel Molina Romero. Head of the Tropical Medicine and International Health Unit. General Hospital Infectious Diseases. Vall d'Hebron University Hospital / Head of group Infectious Diseases. Vall d’Hebron Research Institute (VHIR)
